- RESEARCH SUMMARY
Base editor treats progeria in mice
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-021-01114-8
References
Eriksson, M. et al. Nature 423, 293–298 (2003).
De Sandre-Giovannoli, A. et al. Science 300, 2055 (2003).
Gordon, L. B., Brown, W. T. & Collins, F. S. Hutchinson–Gilford Progeria Syndrome (GeneReviews, 2019).
Gordon, L. B. et al. Proc. Natl Acad. Sci. USA 109, 16666–16671 (2012).
Gaudelli, N. M. et al. Nature 551, 464–471 (2017).
Anzalone, A. V., Koblan, L. W. & Liu, D. R. Nature Biotechnol. 38, 824–844 (2020).
Grimm, D. & Zolotukhin, S. Mol. Ther. 23, 1819–1831 (2015).
Competing Interests
D.R.L. is a co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants and Editas Medicine, companies that use genome editing.